In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
July 23rd, 2004 | 15 | Yes |
Popular Name: Altretamine Altretamine
1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'', N''-hexamethyl-
1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N'',N''-hexamethyl-
1,3,5-Triazine-2,4,6-triamine, N,N,N',N',N',N'-hexamethyl-
2,4, 6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-Tris(dimethylamino)-1,3,5-triazine
2,4,6-tris(dimethylamino)-1,3,5-triazine; 2,4,6-tris(dimethylamino)-s-triazine; HMM
2,4,6-Tris(dimethylamino)-s-triazine
2-N,2-N,4-N,4-N,6-N,6-N-hexamethyl-1,3,5-triazine-2,4,6-triamine
645-05-6; Altretamine (USP/INN); D02841; Hexalen (TN)
altretamina; altretamine; altretaminum
Altretamine; CPD000058181; SAM002564241
Altretaminum [INN-Latin];HEXAMETHYLMELAMINE;HMM;HTM;HXM
InChI=1/C9H18N6/c1-13(2)7-10-8(14(3)4)12-9(11-7)15(5)6/h1-6H
MGI Pharma Brand of Altretamine
N,N,N',N',N'',N''-hexamethyl-1,3,5-triazine-2,4,6-triamine
N~2~,N~2~,N~4~,N~4~,N~6~,N~6~-Hexamethyl-1,3,5-triazine-2,4,6-triamine
Rhone Poulenc Rorer Brand of Altretamine
Rhone-Poulenc Rorer Brand of Altretamine
s-Triazine, 2,4,6-tris(dimethylamino)-
Wassermann Brand of Altretamine
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 2.18 | 11.48 | -8.91 | 0 | 6 | 0 | 48 | 210.285 | 3 | ↓ |
Mid Mid (pH 6-8) | 2.18 | 11.58 | -23.57 | 1 | 6 | 1 | 50 | 211.293 | 3 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 3.10e+00 g/l | DrugBank-approved |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
UniProt Database Links | ABC3G_CHLAE; ABC3G_ERYPA; ABC3G_GORGO; ABC3G_HUMAN; ABC3G_LAGLA; ABC3G_MACFA; ABC3G_MACMU; ABC3G_MACNG; ABC3G_PANPA; ABC3G_PANTR; ABC3G_PAPAN; ABC3G_PONPY; ABC3G_SAGLB; MYH11_CHICK; MYH11_HUMAN; MYH11_MOUSE; MYH11_PIG; MYH11_RABIT; MYH11_RAT; MYH13_CANFA | ChEBI |
Therapy | antineoplastic | SMDC Pharmakon |
Target | DNA alkylator | Selleck Chemicals |
Patent Database Links | EP1502604; EP1537858; EP1538164; EP1580188; EP1676576; EP1717247; EP1728863; EP1938798; EP1990342; US2002165218; US2005009845; US2005130980; US2005187267; US2006014755; US2006030555; US2006040958; US2006041131; US2006069103; US2006094706; US2006106023; US | ChEBI |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : T-8612; NCC_SUPPLIER_SAMPLE_COMMENTS : WHITE POWDER | NIH Clinical Collection via PubChem |
Target | Others | Selleck Chemicals |
Indications | ovarian cancer | KeyOrganics Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: T-8612; SUPPLIER_COMMENTS: WHITE POWDER | NIH Clinical Collection via PubChem |